xRead - September 2022

Wise et al.

Page 244

1249. Karaki M, Akiyama K, Mori N. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids. Auris Nasus Larynx. 2013;40:277–281. [PubMed: 23127728] 1250. Kronholm A Injectable depot corticosteroid therapy in hay fever. J Int Med Res. 1979;7:314– 317. [PubMed: 385402] 1251. Ohlander BO, Hansson RE, Karlsson KE. A comparison of three injectable corticosteroids for the treatment of patients with seasonal hay fever. J Int Med Res. 1980;8:63–69. [PubMed: 7358206] 1252. Laursen LC, Faurschou P, Pals H, Svendsen UG, Weeke B. Intramuscular betamethasone dipropionate vs. oral prednisolone in hay fever patients. Allergy. 1987;42:168–172. [PubMed: 3592139] 1253. Laursen LC, Faurschou P, Munch EP. Intramuscular betamethasone dipropionate vs. topical beclomethasone dipropionate and placebo in hay fever. Allergy. 1988;43:420–424. [PubMed: 3189722] 1254. Borum P, Gronborg H, Mygind N. Seasonal allergic rhinitis and depot injection of a corticosteroid. Evaluation of the efficacy of medication early and late in the season based on detailed symptom recording. Allergy. 1987;42:26–32. [PubMed: 3551670] 1255. Aasbjerg K, Torp-Pedersen C, Vaag A, Backer V. Treating allergic rhinitis with depot-steroid injections increase risk of osteoporosis and diabetes. Respir Med. 2013;107:1852–1858. [PubMed: 24090789] 1256. Mygind N, Laursen LC, Dahl M. Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy. Allergy. 2000;55:11–15. 1257. Wall JW, Shure N. Intranasal cortisone; preliminary study. AMA Arch Otolaryngol. 1952;56:172–176. [PubMed: 14943337] 1258. Sidi E, Tardif R. [Treatment of allergic rhinitis accompanied by eczema with hydrocortisone acetate injected into nasal mucous membrane]. Sem Hop. 1955;31:1922–1923. French. [PubMed: 14396427] 1259. Simmons MW. Intranasal injection of corticosteroids. Calif Med. 1960;92:155–158. [PubMed: 14446887] 1260. Baker DC Jr, Strauss RB. Intranasal injections of long acting corticosteroids. Ann Otol Rhinol Laryngol. 1962;71:525–531. [PubMed: 13864129] 1261. Mabry RL. Intraturbinal steroid injection: indications, results, and complications. South Med J. 1978;71:789–791, 794. [PubMed: 663723] 1262. Yang TY, Jung YG, Kim YH, Jang TY. A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy. Otolaryngol Head Neck Surg. 2008;139:367–371. [PubMed: 18722214] 1263. Mabry RL. Intranasal corticosteroid injection: indications, technique, and complications. Otolaryngol Head Neck Surg (1979). 1979;87:207–211. [PubMed: 503490] 1264. Rowe RJ, Dusler TW, Kinkella AM. Visual changes and triamcinolone. JAMA. 1967;201:333. 1265. Byers B Blindness secondary to steroid injections into the nasal turbinates. Arch Ophthalmol. 1979;97:79–80. [PubMed: 758896] 1266. Martin PA, Church CA, Petti GH Jr, Hedayi R. Visual loss after intraturbinate steroid injection. Otolaryngol Head Neck Surg. 2003;128:280–281. [PubMed: 12601327] 1267. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol. 1988;81:580–589. [PubMed: 2450113] 1268. Meltzer EO, Jalowayski AA, Orgel HA, Harris AG. Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray. J Allergy Clin Immunol. 1998;102:39–49. [PubMed: 9679846] 1269. Baroody FM, Cruz AA, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. J Allergy Clin Immunol. 1992;90:373–376. [PubMed: 1527319]

Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Int Forum Allergy Rhinol . Author manuscript; available in PMC 2020 June 10.